KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Shares Outstanding (Weighted Average) (2016 - 2025)

Charles River Laboratories International has reported Shares Outstanding (Weighted Average) over the past 17 years, most recently at $49.6 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) fell 3.53% year-over-year to $49.6 million; the TTM value through Dec 2025 reached $49.6 million, down 3.53%, while the annual FY2025 figure was $49.6 million, 3.53% down from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $49.6 million at Charles River Laboratories International, roughly flat from $49.7 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $51.5 million in Q2 2024 and troughed at $49.6 million in Q4 2025.
  • A 5-year average of $50.7 million and a median of $50.8 million in 2022 define the central range for Shares Outstanding (Weighted Average).
  • Biggest five-year swings in Shares Outstanding (Weighted Average): grew 1.61% in 2021 and later dropped 3.53% in 2025.
  • Year by year, Shares Outstanding (Weighted Average) stood at $50.3 million in 2021, then increased by 1.03% to $50.8 million in 2022, then increased by 0.82% to $51.2 million in 2023, then increased by 0.3% to $51.4 million in 2024, then dropped by 3.53% to $49.6 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for CRL at $49.6 million in Q4 2025, $49.7 million in Q3 2025, and $49.9 million in Q2 2025.